Related Experiment Video
Updated: Apr 7, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Study on the Effect of Atropinesterase on Intraocular Atropine Metabolism
Tian Han1,2,3,4, Yuliang Wang1,2,3,4, Xiaoliao Peng1,2,3,4
1Department of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China.
Purpose:
Atropine is an important medicine for myopia control in clinical practice, yet individual therapeutic responses vary widely, potentially due to differences in metabolic processes. Atropinesterase (AE), the enzyme catalyzing atropine hydrolysis, may critically influence its bioavailability and efficacy. This study investigated the role of AE in intraocular atropine metabolism.
Methods:
In total, 28 New Zealand White rabbits were screened for plasma AE activity using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). From these, 14 rabbits [7 AE-positive (AE+) and 7 AE-negative (AE-)] were selected for the drug administration study. A single 50-μL dose of 1% atropine sulfate was administered topically to the right conjunctival sac of each animal. Then 24 h post-administration, ocular tissues (including cornea, iris, retina, choroid, aqueous humor, vitreous, and anterior/posterior sclera) were collected. Tissue atropine concentrations were quantified by validated HPLC-MS/MS methods. For statistical analysis, tissue-specific atropine distributions were evaluated using generalized linear mixed-effects models.
Results:
Briefly, 35.71% of rabbits were identified as AE+. AE activity significantly reduced atropine levels in aqueous humor (P = 0.001), iris (P = 0.030), choroid (P = 0.031), and vitreous (P = 0.001) in AE+ rabbits than in AE- rabbits. In both AE- and AE+ eyes, the top 3 atropine-concentrated tissues were anterior sclera, cornea, and posterior sclera.
Conclusions:
AE markedly accelerates intraocular atropine metabolism, leading to significant concentration disparities across ocular tissues. The metabolic principle revealed in rabbits-that higher enzymatic activity limits drug availability-likely applies to humans and offers a new perspective on interindividual efficacy variations of atropine in myopic children.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Cholinergic Antagonists: Pharmacokinetics

